AMBER MARTIN: Open Payments
NPI 1407353493 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$802 in 27 payments from 15 companies in 2025. Trend: 2023 $132 · 2024 $125 · 2025 $802
Food & beverage: $703Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $171 |
| Merck Sharp & Dohme LLC | 4 | $116 |
| Daiichi Sankyo Inc. | 4 | $110 |
| Ipsen Biopharmaceuticals, Inc | 2 | $69 |
| ABBVIE INC. | 2 | $58 |
| SOBI, INC | 1 | $43 |
| Astellas Pharma US Inc | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| Celgene Corporation | 1 | $28 |
Products named: ERLEADA, ENHERTU, Onivyde, LYNPARZA, DATROWAY, Vonjo, Nubeqa, KEYTRUDA.
Industry payments across TX — which companies pay providers there.
